Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 4
1956 1
1957 4
1958 2
1962 1
1976 1
1988 1
1993 2
2000 3
2004 1
2006 11
2007 17
2008 24
2009 15
2010 5
2011 4
2012 2
2013 1
2014 2
2017 1
2020 3
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 17942772

104 results
Results by year
Filters applied: . Clear all
Page 1
Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets.
Fishbane S, Besarab A. Fishbane S, et al. Clin J Am Soc Nephrol. 2007 Nov;2(6):1274-82. doi: 10.2215/CJN.02380607. Epub 2007 Oct 17. Clin J Am Soc Nephrol. 2007. PMID: 17942772 Free article. Review.
The treatment of anemia in chronic kidney disease: understandings in 2006.
Levin A. Levin A. Curr Opin Nephrol Hypertens. 2007 May;16(3):267-71. doi: 10.1097/MNH.0b013e32805b7257. Curr Opin Nephrol Hypertens. 2007. PMID: 17420672 Review.
Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?
Vaziri ND. Vaziri ND. Nat Clin Pract Nephrol. 2008 Aug;4(8):436-45. doi: 10.1038/ncpneph0847. Epub 2008 Jun 10. Nat Clin Pract Nephrol. 2008. PMID: 18542121 Review.
Continuous erythropoietin receptor activator (Mircera) for renal anemia.
McGahan L. McGahan L. Issues Emerg Health Technol. 2008 Feb;(113):1-6. Issues Emerg Health Technol. 2008. PMID: 18354858
What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level?
Singh AK. Singh AK. Curr Opin Nephrol Hypertens. 2010 Sep;19(5):420-4. doi: 10.1097/MNH.0b013e32833cf1d6. Curr Opin Nephrol Hypertens. 2010. PMID: 20689425 Review.
Triumph and tragedy: anemia management in chronic kidney disease.
Novak JE, Szczech LA. Novak JE, et al. Curr Opin Nephrol Hypertens. 2008 Nov;17(6):580-8. doi: 10.1097/MNH.0b013e32830c488d. Curr Opin Nephrol Hypertens. 2008. PMID: 18941350 Review.
The optimal hemoglobin in dialysis patients- a critical review.
Singh AK, Fishbane S. Singh AK, et al. Semin Dial. 2008 Jan-Feb;21(1):1-6. doi: 10.1111/j.1525-139X.2007.00329.x. Semin Dial. 2008. PMID: 18251947 Review.
Anemia, renal transplantation, and the anemia paradox.
Rigatto C. Rigatto C. Semin Nephrol. 2006 Jul;26(4):307-12. doi: 10.1016/j.semnephrol.2006.05.007. Semin Nephrol. 2006. PMID: 16949469 Review.
Exceeding hemoglobin target levels in US hemodialysis patients receiving epoetin, 1999 to 2002.
Foley RN, Zhang R, Gilbertson DT, Dunning S, Ishani A, Collins AJ. Foley RN, et al. Hemodial Int. 2007 Jul;11(3):333-9. doi: 10.1111/j.1542-4758.2007.00189.x. Hemodial Int. 2007. PMID: 17576299
[Regarding the optimal hemoglobin target range in renal anemia].
Maurin N. Maurin N. Med Klin (Munich). 2008 Sep 15;103(9):633-7. doi: 10.1007/s00063-008-1102-3. Epub 2008 Sep 24. Med Klin (Munich). 2008. PMID: 18813886 Review. German.
104 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback